findmyKOL
Clinical trialNCT04743076SuspendedInterventional

A Randomized Trial Of Endovascular Treatment For Acute Posterior Large Vessel Occlusion

SponsorXinqiao Hospital of ChongqingEnrollment386Vertebrobasilar Stroke
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jeffrey L Saver, MD

    Neurology, University of California, Los Angeles, USA

    Principal Investigator
  • Qingwu Yang, MD

    Neurology, Xinqiao Hospital of the Army Medical University

    Principal Investigator
  • Raul G Nogueira, MD

    Marcus Stroke & Neuroscience Center, Grady Memorial Hospital, Emory University, Atlanta, USA

    Principal Investigator
  • Wenjie Zi, MD

    Neurology, Xinqiao Hospital of the Army Medical University

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

  • Yijishan Hospital of Wannan Medical College

    Wuhu, Anhui, China

  • Banan District People'S Hospital

    Banan, Chongqing Municipality, China

  • Xinqiao Hospital of Army Medical University

    Chongqing, Chongqing Municipality, China

  • Jiangmen Central Hospital

    Jiangmen, Guangdong, China

  • Wuyi Traditional Chinese Medicine Hospital

    Jiangmen, Guangdong, China

  • Maoming Traditional Chinese Medicine Hospital

    Maoming, Guangdong, China

  • Chinese Medical Hospital of Zhongshan

    Zhongshan, Guangdong, China

  • the 924th Hospital of Cpla

    Guilin, Guangxi, China

  • Danzhai People'S Hospital

    Longquan, Guizhou, China

  • Nanyang Central Hospital

    Nanyang, Henan, China

  • Wuhan No. 1 Hospital

    Wuhan, Hubei, China

  • the 904th Hospital of Cpla

    Wuxi, Jiangsu, China

  • Xuzhou Central Hospital

    Xuzhou, Jiangsu, China

  • the First Affiliated Hospital of Jilin University

    Changchun, Jilin, China

  • the Affiliated Hospital of Southwest Medical University

    Luzhou, Sichuan, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Mar 2021
Primary completion
16 May 2024
Completion
16 May 2024
Last update posted
14 Sept 2021
Registered enrollment
386
Registry id
NCT04743076

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.